Case Investigations

The GEO Group, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of The GEO Group, Inc. (“GEO Group” or the “Company”) (NYSE: GEO).  A complaint has been filed on behalf of investors that purchased or otherwise acquired GEO Group securities between February 27, 2020 and June 16, 2020, inclusive (the “Class Period”).

Tufin Software Technologies Ltd.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Tufin Software Technologies Ltd. (“Tufin” or the “Company”) (NYSE: TUFN).

J2 Global, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of J2 Global, Inc. (“J2 Global” or the “Company”) (NASDAQ: JCOM). A complaint has been filed on behalf of investors that purchased or otherwise acquired the publicly traded securities of J2 Global between October 5, 2015 and June 29, 2020, inclusive (the “Class Period”).

Verrica Pharmaceuticals Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ: VRCA).  A complaint has been filed on behalf of investors that purchased Verrica securities between September 16, 2019 and June 29, 2020, inclusive (the “Class Period”).

Guidewire Software Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Guidewire Software Inc. (“Guidewire” or the “Company”) (NASDAQ: GWRE).  A complaint has been filed on behalf of investors that purchased Guidewire common stock between March 6, 2019 and March 4, 2020, inclusive (the “Class Period”).

Energy Recovery, Inc.

August 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Energy Recovery, Inc. (“Energy Recovery” or the “Company”) (NASDAQ: ERII).  A complaint has been filed on behalf of investors that purchased Energy Recovery shares between August 2, 2017 and June 20, 2020, inclusive (the “Class Period”).

Vaxart, Inc.

July 27, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Vaxart, Inc. (“Vaxart” or the “Company”) (NASDAW: VXRT).

Two Energy Harbor Power Plants

July 21, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of FirstEnergy Corp. (“FirstEnergy” or the “Company”) (NYSE: FE) and its former subsidiary Energy Harbor Corp. (“Energy Harbor) (OTC: ENGH) .  Investors who purchased FirstEnergy or Energy Harbor securities may be affected.

Wirecard AG

June 19, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Wirecard AG (“Wirecard” or the “Company”) (OTC: WCAGY).

Chembio Diagnostics, Inc.

June 17, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims against Chembio Diagnostics, Inc. (“Chembio”) for violations of the federal securities laws.

Carnival Corporation

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Carnival Corporation (“Carnival” or the “Company”).  A complaint has been filed on behalf of investors that purchased or acquired Carnival common stock (NYSE: CCL) or American Depository Shares (NYSE: CUK) between September 26, 2019 and April 30, 2020, inclusive (the “Class Period”).

Hamilton Beach Brands

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Hamilton Beach Brands Holding Company (“Hamilton Beach” or the “Company”) (NYSE: HBB).  A complaint has been filed against the Company on behalf of investors that purchased or acquired Hamilton Beach securities between February 27, 2020 and May 8, 2020, inclusive (the “Class Period”).

Elanco Animal Health

June 10, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN).  A complaint has been filed on behalf of investors that purchased or acquired Elanco Animal securities between January 10, 2020 and May 6, 2020, inclusive (the “Class Period”).

Conn's Inc.

May 22, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Conn’s Inc. (“Conn’s” or the “Company”) (NASDAQ: CONN) that purchased Conn’s securities between September 3, 2019 and December 9, 2019, inclusive (the “Class Period”).

Hallmark Financial Services

May 19, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Hallmark Financial Services (“Hallmark Financial” or the “Company”) (NASDAQ: HALL) that purchased Hallmark Financial securities between March 5, 2019 and March 17, 2020, inclusive (the “Class Period”).

Recro Pharma, Inc.

May 11, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Recro Pharma, Inc. (“Recro Pharma” or the “Company”) (NASDAQ: REPH).  Investors who purchased Recro Pharma securities may be affected.

CNS Pharmaceurticals, Inc.

May 8, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CNS Pharmaceuticals, Inc. (“CNS” or the “Company”) (NASDAQ: CNSP).  Investors who purchased CNS securities may be affected.

Moleculin Biotech, Inc.

May 8, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Moleculin Biotech, Inc. (“Moleculin” or the “Company”) (NASDAQ: MBRX).  Investors who purchased Moleculin securities may be affected.

Wells Fargo & Company

May 7, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Wells Fargo & Company (“Wells Fargo” or the “Company”) (NYSE: WFC).

Tal Education Group

April 24, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Tal Education Group (“TAL” or the “Company”) (NYSE: TAL).  Investors who purchased TAL securities, including TAL American Depositary Receipts (ADRs), may be affected.

iQIYI, Inc.

April 8, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of iQIYI, Inc. (“iQIYI” or the “Company”) (NASDAQ: IQ).  Investors who purchased iQIYI securities, including iQIYI American Depositary Shares (ADSs), may be affected.

Investigation of "Inclusive Access" Textbook and Course Material System

March 11, 2020 – KAPLAN FOX & KILSHEIMER, LLP INVESTIGATING POTENTIAL LEGAL VIOLATIONS INVOLVING “INCLUSIVE ACCESS” TEXTBOOK AND COURSE MATERIAL SYSTEM USED BY CURRENT AND FORMER STUDENTS AT NUMEROUS U.S. COLLEGES AND UNIVERSITIES

Bruker Corporation

March 6, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bruker Corporation (“Bruker” or the “Company”) (NASDAQ: BRKR).  Investors who purchased Bruker securities may be affected.

Dorman Products, Inc.

March 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Dorman Products, Inc. (“Dorman” or the “Company”) (NASDAQ: DORM).  Investors who purchased Dorman securities may be affected.

Newell Brands, Inc.

March 4, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Newell Brands, Inc. (“Newell Brands” or the “Company”) (NASDAQ: NWL).  Investors who purchased Newell Brands securities may be affected.

CarGurus, Inc.

February 19, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CarGurus, Inc. (“CarGurus” or the “Company”) (Nasdaq: CARG).  Investors who purchased CarGurus securities may be affected.

LivePerson, Inc.

February 14, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of LivePerson, Inc. (“LivePerson” or the “Company”) (NASDAQ: LPSN).  Investors who purchased LivePerson securities may be affected.

Bed Bath & Beyond Inc.

February 13, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bed Bath & Beyond Inc. (“Bed Bath & Beyond” or the “Company”) (Nasdaq: BBBY).  Investors who purchased Bed Bath & Beyond securities may be affected.

Insperity, Inc.

February 12, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Insperity, Inc. (“Insperity” or the “Company”) (NYSE: NSP).  Investors who purchased Insperity securities may be affected.

Sasol Limited

February 11, 2020 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Sasol Limited (“Sasol” or the “Company”) (NYSE: SSL).  A class action securities lawsuit has been filed on behalf of investors who purchased Sasol securities, including Sasol American Depositary Receipts (“ADRs”), between March 10. 2015 and January 13, 2020, inclusive (the “Class Period”).